Home
>
National Drug Code (NDC)
>
Lovastatin
Lovastatin - 51079-975-20 - (Lovastatin)
Drug Information of Lovastatin
| Product NDC: | 51079-975 |
| Proprietary Name: | Lovastatin |
| Non Proprietary Name: | Lovastatin |
| Active Ingredient(s): | 20 mg/1 & nbsp; Lovastatin |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Lovastatin
| Product NDC: | 51079-975 |
| Labeler Name: | Mylan Institutional Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA075451 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20121102 |
Package Information of Lovastatin
| Package NDC: | 51079-975-20 |
| Package Description: | 100 BLISTER PACK in 1 BOX, UNIT-DOSE (51079-975-20) > 1 TABLET in 1 BLISTER PACK (51079-975-01) |
NDC Information of Lovastatin
| NDC Code | 51079-975-20 |
| Proprietary Name | Lovastatin |
| Package Description | 100 BLISTER PACK in 1 BOX, UNIT-DOSE (51079-975-20) > 1 TABLET in 1 BLISTER PACK (51079-975-01) |
| Product NDC | 51079-975 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Lovastatin |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20121102 |
| Marketing Category Name | ANDA |
| Labeler Name | Mylan Institutional Inc. |
| Substance Name | LOVASTATIN |
| Strength Number | 20 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | HMG-CoA Reductase Inhibitor [EPC],Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA] |
